RE: To days results18 Mar 2021 12:17
Cashola - they may have made 0.25% interest on the deferred VAT liability, but thats all - that Q1 2020 liability will need to be paid down next month.
Its Bal Sheet only (Dr bank/Cr VAT liability = was part of balance sheet cash only - no P&L effect)
Having worked in M&A for 20 years Let me also try explain EBT one last time!
Capita EBT for 2020 was 116M.
Deduct ESS (for purposes of recurring profit reporting) of 51M leave post ESS business EBT of 65M
We will have 2 mths trading of ESS to add back into 2021 but I have ignored that)
The "below the line" items of impairment of goodwill, one off items eg. cost to close offices etc were (Net) approx 115M to show the continued operations headline loss 50M
Those one off costs are never considered in valuations
The company has said that their CV19 reactions (eg closing offices etc) will save year on year 120M starting 2021 (with additional 2022 circa 50M)
I have worked in M&A for 20 years - if valuing a private business we would often use EBITDA multiples for valuation - here I have used Continued operations EBT with fwd looking "known" adjustments.
If you listen to yesterdays Investor presentation and read the slides that accompany them, then you will understand the business a little better.
So for the umpteenth time - Capita EBT last year was 116M ( before deducting ESS for fwd looking, and accounting adj that used to be call "exceptional")
My calcs above clearly start with EBT at the 2020 level of 116M and for valuation methods deduct ESS non recurring 51M
The rest of the figures are those that we provided to IIs in the presentation
The market doesnt care about the past that much - it prices on the future - so fwd looking trading EBT on the current business is circa 225M-300M (all things remaining equal ie we dont know what EBT will need to be deducted when the next business sale occurs - but if we achieve 8-10 times multiple for non core then then thats fine in my book)
At this level we have sufficient debt coverage / interest coverage on existing loan notes - the expected bond issue (later this year to replace senior debt) will allow for pushing debt repayments out much further
These figures indicate a SP valuation of 120p to 180p - will we get there yet? NO, because CPI need to back it up this year - hence H1 results (by which time AXELOS or others will probably have been sold) will tell us whether they are achieving this
If we consider the low level 120p valuation and assume future business unit sales reduce continued operations EBT by say 50M, therefore 225M-50M = 175M at 10 x multiple indicates approx 100p valuation
As a quick and dirty, Barclays 80p short term indication is probably along these lines until the bond issue happens, by which they will no doubt return to their 100-120p range (possibly 150-180p if CPI is showing they are delivering)
So in summary - Deferred VAT is a nothing effect to P&L, and CapitaTrading EBT for 2020 is